Efficacy and Safety of Sebelipase Alfa in Children and Adults with Lysosomal Acid Lipase Deficiency: Results of a Phase 3 Trial†  Sandra Rojas-Caro, Barbara.

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages (March 2003) DOI: /S X(03) Copyright.
National Guidelines for Nursing Delegation
Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review  X.-F. Gao, Z.-W. Yang, J. Li  International.
Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,
Volume 61, Issue 5, Pages (November 2014)
Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels†  Eli.
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.
An assessment by the Statin Cognitive Safety Task Force: 2014 update
An assessment by the Statin Muscle Safety Task Force: 2014 update
An assessment by the Statin Liver Safety Task Force: 2014 update
Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients  Evan Stein, MD, Harold Bays, MD, Michael Koren,
Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,
Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results.
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
Normal Weight-Central Obesity Is Associated with the Highest Mortality Risk in Older Adults with Coronary Artery Disease*†  Saurabh Sharma, MD, John A.
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C- III levels in patients from the MARINE and ANCHOR studies  Christie.
Predictors of first-year statin medication discontinuation: A cohort study  Heli Halava, MD, Risto Huupponen, MD, PhD, Jaana Pentti, BSc, Mika Kivimäki,
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data  Steve E. Humphries, PhD, FRCP, Jackie Cooper,
Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study) 
Practice Notes from the AAAI
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized.
Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth  Catherine J. McNeal, MD, PhD, Justin Zachariah, MD, MPH, Laurel Copeland,
Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?  Joana Rita Chora, MSc, Ana Catarina Alves, PhD, Ana.
Eveline Oestreicher Stock, MD, Christine T
Charles J. Glueck, MD, Alan Brown, MD, Anne C. Goldberg, MD, James M
Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth  Catherine J. McNeal, MD, PhD, Justin Zachariah, MD, MPH, Laurel Copeland,
Paul D. Thompson, MD, John Rubino, MD, Matthew J. Janik, MD, Diane E
Short Total Sleep Time and Elevated Central Apnea Index are Significant Predictors of Coronary Artery Disease*  Tina Constantin, MD, Jeremy R. Anthony,
An assessment by the Statin Intolerance Panel: 2014 update
Volume 61, Issue 5, Pages (November 2014)
Extended-Release Niacin/Laropiprant Lowers Serum Phosphorus Concentrations in Patients with Type 2 Diabetes and Mild Hyperphosphatemia  Andrew G. Bostom,
Controlled clinical trials in cystic fibrosis — are we doing better?
Epidemiology of opportunistic infections in AIDS patients
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.
Databases for Clinical Research
Practice Notes from the AAAAI
Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia  Raul D. Santos, Frederick J. Raal,
News & Notes Journal of Allergy and Clinical Immunology
Support Your Specialty
Sokunthea Peou, PharmD, Brittany Milliard-Hasting, MD, Sachin A
Editorial Board Orthopedic Clinics Volume 48, Issue 3, (July 2017)
Editorial Board Orthopedic Clinics Volume 47, Issue 3, (July 2016)
Star Trek Publishing Journal of Investigative Dermatology
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Table of contents The Journal for Nurse Practitioners
Democratizing the Clinical Trials Agenda in Dermatology
Christopher S. Penet, Brian H. Annex, MD, Kelly T. Gregory, R
Reviewer Acknowledgment
News & Notes Journal of Allergy and Clinical Immunology
Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review  Ilse K. Luirink, MD, Jim.
Table of contents The Journal for Nurse Practitioners
Preface Clinics in Liver Disease
Journal of Investigative Dermatology
Issue Highlights Clinical Gastroenterology and Hepatology
Can Low-Radiation Coronary Computed Tomography Angiography Improve Upon Clinical Risk Assessment in Patients with Familial Hypercholesterolemia?*  Anna.
A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine  Donald G. Lamprecht, PharmD, Anne M.
Practice Notes from the AAAI
Discussion The Journal of Thoracic and Cardiovascular Surgery
Direct Observation of Residents: A Model for an Assessment System
Prediction of Cardiovascular Disease Events by Lipoprotein(a) According to LDL-C in Older High Risk Adults  Nathan D. Wong, PhD, Shravanthi R. Gandra,
Footnotes1 Journal of Allergy and Clinical Immunology
Editorial Board Orthopedic Clinics Volume 47, Issue 2, (April 2016)
Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol—The role of LDL-apheresis  Mary P. McGowan, MD, FNLA 
Volume 50, Issue 2, Pages iii-iv (April 2019)
News & Notes Journal of Allergy and Clinical Immunology
Presentation transcript:

Efficacy and Safety of Sebelipase Alfa in Children and Adults with Lysosomal Acid Lipase Deficiency: Results of a Phase 3 Trial†  Sandra Rojas-Caro, Barbara Burton, Vassili Valayannopoulos, Manisha Balwani, John Kane, Zachary Goodman, Yijun Yang, Anthony Quinn  Journal of Clinical Lipidology  Volume 9, Issue 3, Pages 429-430 (May 2015) DOI: 10.1016/j.jacl.2015.03.036 Copyright © 2015 Terms and Conditions

Journal of Clinical Lipidology 2015 9, 429-430DOI: (10. 1016/j. jacl Copyright © 2015 Terms and Conditions

Journal of Clinical Lipidology 2015 9, 429-430DOI: (10. 1016/j. jacl Copyright © 2015 Terms and Conditions